RAD9A anticorps (C-Term)

N° du produit ABIN1929015

Cet anticorps anti-RAD9A est un anticorps Lapin Polyclonal détectant RAD9A dans WB, IHC, IHC (p), IF, IP et PLA. Adapté pour Humain, Chien, Boeuf (Vache) et Porc.

Aperçu rapide pour RAD9A anticorps (C-Term) (ABIN1929015)

Antigène: RAD9A (RAD9 Homolog A (S. Pombe) (RAD9A))

Reactivité: Humain, Chien, Boeuf (Vache), Porc

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RAD9A est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF), Immunoprecipitation (IP), Proximity Ligation Assay (PLA)

Détail du produit anti-RAD9A anticorps

Épitope: AA 350-391, C-Term

Specificité: Region between residue 350 and the C-terminus (residue 391) of human Rad9 using the numbering given in entry NP_004575.1 (GeneID 5883).

Purification: Immunoaffinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: IF (1:250 - 1:1000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate), PLA (1:1000 - 1:10000), WB (1:2000 - 1:10000)

Usage: Immunohistochemistry: Antigen retrieval with citrate buffer  pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Ovarian Carcinoma, Prostate Carcinoma.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Tris-citrate/phosphate buffer,  pH 7-8, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C for up to 1 year.

Date de péremption: 12 months

Détails sur RAD9A

Antigène: RAD9A (RAD9 Homolog A (S. Pombe) (RAD9A))

Autre désignation: RAD9A / RAD9

Sujet: Name/Gene ID: RAD9A

Synonyms: RAD9A, HRAD9, RAD9, RAD9 homolog, RAD9 (S. pombe) homolog, RAD9 homolog A (S. pombe)

ID gène: 5883

Pathways: Positive Regulation of Response to DNA Damage Stimulus